Research and Development Archives – Treatment Action Group

Story: HIV “completely eliminated” from cells in a laboratory dish with CRISPR technology

March 20, 2024
Dorrit Walsh

March 2024 Media coverage: Scientists say they can cut HIV out of cells - Michelle Roberts, BBC, March 20, 2024 HIV cure breakthrough as virus eliminated from cells in laboratory - Nina Massey, The Independent, March 20, 2024 Hopes of…

2024 CROI Tuberculosis Research Round Up

March 14, 2024
Dorrit Walsh

Treatment Action Group (TAG) welcomes the tuberculosis (TB) data presented at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI). The highlights presented here cover the results of several phase II TB prevention and treatment trials.

Policy Issue Briefs: BARDA and ARPA-H

March 11, 2024
Dorrit Walsh

These two policy briefs explore two as yet untapped sources for drug-resistant tuberculosis (DR-TB) research funding within the U.S. Department of Health and Human Services (HHS).

Image that reads: 2024 HIV Cure Research Community Workshop. White text on a mostly green background

2024 Pre-CROI Community HIV Cure Research Workshop

March 2, 2024
Dorrit Walsh

The 2024 Pre-CROI Community HIV Cure Research Workshop took place on Saturday, March 2nd in Denver. This year’s workshop had a shorter format than in the past, but we plan to return to an all-day event in the future.

Washington D.C. Community Consensus on the Earlier Inclusion of Pregnant Women and Persons in TB Research

February 28, 2024
Dorrit Walsh

In October 2023, sixteen members of the global TB community developed a consensus statement on the inclusion of pregnant and breastfeeding women and persons in TB treatment and vaccines research.

Communities as Actors in the Research and Development Process

December 13, 2023
Dorrit Walsh

This publication explores the role of community engagement in health-related research and development (R&D), particularly within the Unitaid-funded LONGEVITY Project.

Report: TB R&D Funding Perilously Off Track of UN Commitments to End Disease by 2030

December 5, 2023
Dorrit Walsh

A new report released today by Treatment Action Group (TAG) and the Stop TB Partnership has found that cumulative funding for tuberculosis (TB) research and development (R&D) over the past five years is falling shockingly short of commitments.

Report cover - graphic representation of a target and the text reads: Tuberculosis Research Funding Trends, 2005-2022

2023 Report on TB Research Funding Trends

December 5, 2023
Dorrit Walsh

Tuberculosis Research Funding Trends 2005 – 2022, the 18th annual installment of our series assessing the state of TB R&D, is based on surveys of biomedical research funders conducted by TAG with support from Stop TB Partnership.

Story: CRISPR-Based Cure for HIV “could be months away”

November 8, 2023
Dorrit Walsh

October/November 2023 Media coverage: CRISPR gene therapy appears safe, but claims of an imminent HIV cure are premature - Liz Highleyman, AIDSMap, November 3, 2023 Cure for HIV could be months away as first three patients are injected with new…

Treatment Action Group Resource on the Demographics of Participation in HIV Cure-Related Clinical Research

October 16, 2023
Dorrit Walsh

In 2014, TAG began tracking HIV cure-related trials and observational studies and making the information available as a listing on our website. The primary sources are online study registries, particularly the US-based clinicaltrials.gov.